Studies in target-based treatment.
Kurzrock
Razelle
R
Phase I Program, Division of Cancer Medicine, Unit 422, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. rkurzroc@mdanderson.org
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
D000970:Antineoplastic Agents